期刊文献+

中性内肽酶与心血管疾病关系的研究进展 被引量:1

下载PDF
导出
摘要 中性肽链内切酶(NEP)能降解许多血管活性肽,研究表明在充血性心力衰竭动物模型中,肾脏NEP蛋白含量、活性及表达是增高的。本文主要综述抑制NEP在心血管疾病中作用的研究进展。
出处 《心脏杂志》 CAS 2008年第1期99-100,103,共3页 Chinese Heart Journal
  • 相关文献

参考文献10

  • 1Knecht M, Pangl I, Langenickel T,et al. Increased expression of renal neutral endopeptidase in severe heart failure [ J]. Life Sci 2002, 71(23) :2701 -2712. 被引量:1
  • 2Hu Y, Zhang Z, Torsney E ,et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice [J]. J Clin Invest , 2004, 113(9) : 1258 -1265. 被引量:1
  • 3Barber MN, Gaspari TA, Kairuz EM, et al. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia [ J ]. J Vasc Res, 2005, 42(2) :101 -110. 被引量:1
  • 4Barber MN,Kanagasundaram M,Anderson CR,et al. Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia [J] . Cardiovasc Res, 2006, 71 (1):179 - 188. 被引量:1
  • 5Qian J, Haruno A, Asada Y,et al. Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through en-hanced nitric oxide production in rabbit injured, carotid arteries[ J]. Circ Res ,2002,91 ( 11 ) : 1063 - 1069. 被引量:1
  • 6Maki T,Nasa Y,Tanonaka K,et al. Direct inhibition of neutral endopeptidase in vasopeptidase inhibitor-mediated amelioration of cardiac remodeling in rats with chronic heart failure [ J ]. Mol Cell Biochem, 2003,254(1-2): 265-273. 被引量:1
  • 7Mishima T,Tanimura M, Suzuki G, et al. Effects of chronic neutral endopeptidase inhibition on the progression of left ventricular dysfunction and remodeling in dogs with moderate heart failure [ J ]. Cardiovasc Drugs Ther, 2002, 16 (3) : 209 - 214. 被引量:1
  • 8王江,田颖,祝善俊.Aldo与充血性心力衰竭[J].心脏杂志,2006,18(3):362-364. 被引量:3
  • 9毕四锐.常规应用螺内酯联合依那普利治疗老年扩张型心肌病心力衰竭[J].心脏杂志,2006,18(2):228-230. 被引量:1
  • 10杨永曜,李隆贵.心肌细胞凋亡与心室重构的关系[J].心脏杂志,2006,18(1):95-96. 被引量:10

二级参考文献41

  • 1蔡广,李国璋,吉俭,黄燕平.1,6-二磷酸果糖治疗扩张性心肌病急性心力衰竭的疗效[J].心脏杂志,2004,16(5):457-458. 被引量:4
  • 2Jang YM,Kendaiah S,Drew B,et al.Doxombicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats?[J].FEBS Letters,2004,577:483-490. 被引量:1
  • 3Kong JY,Rabkin W.Cytoskeletal actin degradation induced by lovastatin in cardiomyocytes is mediated through caspase-2?[J].Cell Biol Int,2004,28:781 -790. 被引量:1
  • 4Philipp S,Pagel Ⅰ,Hohnel K,et al.Regulation of caspase-3 and Fas in pressure overload-induced left ventricular dysfunction[J].Eur J Heart Fail,2004,6:845-851. 被引量:1
  • 5Sallee D,Qiu Y,Liu J,et al.Fas ligand gene transfer to the embryonic heart induces programmed cell death and outflow tract defects[J].Dev Biol,2004,267:309 -319. 被引量:1
  • 6Dzimiri N,Al-Bahnasi K,Al-Halees Z.Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload[J].Fundam Clin Pharmacol,2004,18 (1):39 -44. 被引量:1
  • 7Qin F,Liang MC,Liang CS.Progressive left ventricular remodeling,myocyte apoptosis,and protein signaling cascades after myocardial infarction in rabbits[J].Biochim Biophys Acta,2005,1740(3):499-513. 被引量:1
  • 8Lancel S,Petillot P,Favory R,et al.Expression of apoptosis regulatory factors during myocardial dysfunction in endo toxemic rats[J].Crit Care Med,2005,33 (3):492-496. 被引量:1
  • 9Peker C,Sarda-Mantel L,Loiseau P.Imaging apoptosis with 99mTcanuexin-V in experimental subacute myocarditis[J].J Nucl Med,2004,45 (6):1081-1086. 被引量:1
  • 10Mak KM,Wen K,RenC,et al.Dilinoleoylphosphatidylcholine reproduces the antiapoptotic actions of polyenylphosphatidylcholine against ethanol-induced hepatocyte apoptosis[J].Alcohol Clin Exp Res 2003,27(6):997-1005. 被引量:1

共引文献11

同被引文献28

  • 1李春元.利钠肽及血管肽酶抑制剂的心肾保护作用[J].世界临床药物,2004,25(9):558-560. 被引量:4
  • 2张立军,李晓慧,陈玉彬.血管肽酶抑制剂的研究进展[J].沈阳药科大学学报,2006,23(5):328-334. 被引量:1
  • 3王素敏.脑钠肽在心力衰竭中的临床意义[J].中国医学文摘(内科学),2006,27(4):328-331. 被引量:4
  • 4张伟光,李树青.高血压左心室肥厚药物治疗进展[J].心脏杂志,2007,19(3):345-346. 被引量:3
  • 5Mukaddam-Daher S. Natriuretic peptides as therapeutic targets [J]. Expert Opin Ther Targets, 2006, 10(2):239-252. 被引量:1
  • 6Trippodo N C, Fox M, Monticello T M, et al. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril [J]. J Cardiovasc Pharmacol, 1999, 34(6): 782-790. 被引量:1
  • 7Nathisuwan S, Talbert R L. A review of vasopeptidase inhibitors: A new modality in the treatment of hypertension and chronic heart failure [J]. Pharmacotherapy, 2002, 22(1): 27-42. 被引量:1
  • 8Liao W C, Vesterqvist O, Delaney C, et al. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects [J]. Br J Clin Pharmacol, 2003, 56(4): 395-406. 被引量:1
  • 9Dong Y, Zhou H, Shaffer E, et al. The cardiovascular actions of omapatrilat in spontaneously hypertensive rats [J]. Curr Hypertens Rep, 2001, 3(Suppl 2): S 1-S5. 被引量:1
  • 10Backlund T, Palojoki E, Saraste A, et al. Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction [J]. Cardiovasc Res, 2003, 57(3): 727-737. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部